BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 6630618)

  • 1. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
    Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.
    Rhodes AR; Melski JW; Sober AJ; Harrist TJ; Mihm MC; Fitzpatrick TB
    J Invest Dermatol; 1983 May; 80(5):452-9. PubMed ID: 6341476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
    Piepkorn M
    Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
    Cockerell CJ; Berson DS
    Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.
    Rhodes AR; Mihm MC; Weinstock MA
    Mod Pathol; 1989 Jul; 2(4):306-19. PubMed ID: 2762287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of clinical and histopathologic features in clinically atypical melanocytic nevi.
    Barnhill RL; Roush GC
    Cancer; 1991 Jun; 67(12):3157-64. PubMed ID: 2044059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
    Sagebiel RW
    J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The malignant potential of small congenital nevocellular nevi. An estimate of association based on a histologic study of 234 primary cutaneous melanomas.
    Rhodes AR; Sober AJ; Day CL; Melski JW; Harrist TJ; Mihm MC; Fitzpatrick TB
    J Am Acad Dermatol; 1982 Feb; 6(2):230-41. PubMed ID: 7061746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of cutaneous melanoma in a congenital dysplastic nevus spilus.
    Rhodes AR; Mihm MC
    Arch Dermatol; 1990 Apr; 126(4):500-5. PubMed ID: 2321995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplastic melanocytic nevi in histologic association with primary cutaneous melanomas.
    Maize JC
    J Am Acad Dermatol; 1984 May; 10(5 Pt 1):831-5. PubMed ID: 6373857
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management.
    Rhodes AR
    Med Clin North Am; 1986 Jan; 70(1):3-37. PubMed ID: 3510347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased epidermal growth factor receptors in melanocytic lesions.
    Ellis DL; King LE; Nanney LB
    J Am Acad Dermatol; 1992 Oct; 27(4):539-46. PubMed ID: 1383295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.
    Carli P; Massi D; Santucci M; Biggeri A; Giannotti B
    J Am Acad Dermatol; 1999 Apr; 40(4):549-57. PubMed ID: 10188672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous melanocytic lesions: selected problem areas.
    Wick MR; Patterson JW
    Am J Clin Pathol; 2005 Dec; 124 Suppl():S52-83. PubMed ID: 16468418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.